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ABSTRACT
Background: With the increase in the
prevalence of cancer, cancer-related issues also
deserve more attention especially in developing
countries where there is already limited access
to high-quality healthcare. Cancer-related pain,
the most common and the most annoying one,
is not only a symptom but also an important
subspecialty and its management is still
challenging.
Objectives: To assess the level of pain and
cancer pain knowledge in Iran in comparison
with the whole world.
Materials and Method: A search of the
literature including papers published in
PubMed before March 2016 was carried out.
Results: There have been an increasing number
of publications on pain since 1842 and a
growing number of publications on cancer
pain since 1929. There has also been
remarkable growth in our understanding of
cancer pain, particularly since 2010. More
than one-third of studies on pain and
cancer-related pain were published after 2010.
Conclusion: There is a need to be more
inventive with the management of
cancer-related issues, especially pain in
developing countries, to maximize the quality
and quantity of healthcare delivery to
cancer-stricken patients. It seems that
non-governmental organizations like MAHAK
can play a significant role in this goal.
Keywords: Cancer pain; Developing Country;
Iran; Pain
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INTRODUCTION
Cancer is a relatively neglected disease, as declared
by Soyannwo [1], that is still an overriding cause of
pain and suffering, especially in developing
countries [1–4]. According to the World Health
Organization (WHO), 8.2 million people die from
more than 100 types of cancer each year [3]. More
than half of all new cancer cases occur in
developing countries [3, 4], and the incidence of
newcancercases isexpectedto increasebya further
70% in the next two decades [3–6].
Of all the symptoms experienced by cancer
patients, pain is the most common complaint
and, at times, patients can find it intense and
unbearable [7, 8]. Cancer-related pain on average
affects as many as 50–75% of patients worldwide
[9–11]. According to a systematic review by van
den Beuken-van Everdingen et al. evaluating 54
related articles, 59% of patients undergoing
cancer treatment and 64–75% of patients with
advanced disease were affected by pain [9]. As
such, cancer-related pain is a greater problem
during the advanced stages of the disease, which
can become the predominant problem for both
the patients and their families [10–12].
On the basis of van den Beuken-van
Everdingen et al.’s systematic review, more
than one-third of cancer patients graded their
pain as moderate to severe with a visual analogue
scale (VAS) greater than 4 [9]. Likewise, of 258
hospitalized cancer patients interviewed about
their pain in a study by Ripamonti et al., more
than half experienced it in the 24 h prior to their
admission with 27.1% of them regarding it as
high degree [11]. Cancer pain of this intensity is
highly prevalent in resource-poor countries and
this adversely impacts different aspects of
sufferers’ lives including psychological, social,
cultural, and spiritual facets [13]. Female gender,
young age, and prolonged hospitalizations have
been associated with increased pain severity [12].
Since the early 1950s, when John Bonica
highlighted the importance of pain relief, pain
has been recognized, not just as a symptom or
sensation but as a disease in itself [14]. With the
development of pain medicine as a subspecialty
of medical practice in 1989, this domain gained
further popularity. Today, failure in the
adequate treatment of pain is not only
unethical but also illegal [14–16].
Based on WHO guidelines, and depending
on the extremity of pain, step by step
management begins with oral non-opioid
analgesics and progresses through to
parenteral opioids, anticonvulsant agents, or
local anesthetics [17]. There are also diverse
interventional techniques such as spinal
analgesia, nerve block, or destructive
modalities (like radiofrequency ablation
reserved for a minority of patients) [18].
Despite the fact that cost-effective methods
for pain care are available, acute and chronic
pain is still undertreated in developing
countries [13, 19]. There seems to be a large
and widening gap between the increasingly
sophisticated knowledge of pain and the
application of this knowledge to effectively
treat patients [16, 18]. Besides the lack of pain
management training at both undergraduate
and postgraduate levels [20], there are several
other barriers to desirable pain alleviation in
resource-limited settings, including timely
access to healthcare [21] or economic
impediments [22]. However, given the
overwhelming need to treat cancer-related
pain, local advocates have a pivotal role in
developing and implementing innovative
measures, despite the limited resources
available [10, 16, 23, 24]. To overcome the
challenges in the management of cancer-related
pain in developing countries, it is vital that pain
control is embedded in different models of
healthcare delivery. The quality of care given
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must also be strengthened. Both of these needs
can be met through the establishment of
regional and educationally oriented research
centers [10, 16]. This paper offers a concise
summary of the studies that have been
performed in the field of cancer pain and its
management in Iran as one of the developing
countries.
MATERIALS AND METHODS
To assess the level of pain and cancer pain
knowledge in Iran, a brief search of the
literature including papers published in
PubMed before March 2016 (using keywords
‘‘pain’’, ‘‘cancer pain’’ with/without ‘‘Iran’’) was
carried out. This article is based on previously
conducted studies and does not involve any
new studies of human or animal subjects
performed by any of the authors.
RESULTS
The findings illustrated in Figs. 1 and 2 indicate
a significant annual progression in studies
related to pain and cancer pain. There have
been an increasing number of publications on
pain since 1842 and a growing number of
publications on cancer pain since 1929. In
very recent years, there has been remarkable
growth our understanding of cancer pain,
particularly since 2010. In fact, more than
one-third of studies on pain and cancer-related
pain were published after 2010.
DISCUSSION
Iran’s contribution to both pain and
cancer-related pain research has increased in
the last decade. Of the total number of papers
originating from Iran, at least according to the
PubMed database, 91.8% are related to the last
10 years and more than half (61.7%) are related
to the last 5 years. On top of that, the ratio of
cancer pain-related papers to the total papers
about pain has been around 8% which is
slightly less than the corresponding ratio
globally (13%). This significant upward trend
once more highlights the importance of this
topic particularly in developing countries. As a
limitation of our study, we knew that there are
many databases (Google Scholar, Scopus,
EMBASE, etc.) which should be included in a
Fig. 1 Progression in pain research, especially in the recent decade
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more comprehensive literature review;
however, we selected PubMed as one of the
most referred to databanks globally. We suggest
that new projects be undertaken to write an
original or review article in the field of pain
research development.
The growing tendency among Iranian
anesthesiologists to study and practice in pain
medicine spurred the establishment of the
Iranian Society of Regional Anesthesia and
Pain Medicine (ISRAPM) in November 2006.
This society aimed to improve and support
scientific and educational activities within this
field, and in the last decade, there has been an
improvement in pain education and clinical
practice in Iran. This has been achieved by
providing training through pain fellowships
and publishing pain guidelines in
Anesthesiology and Pain Medicine.
Pain relief is a human right [17, 18] and as
such Iranian pain physicians are now
concentrating on performing more native
research projects, publishing research articles,
and managing pain departments and pain
research centers. For example, one of the most
distinguished and successful pain departments is
at MAHAK hospital, which focuses on pediatric
cancer pain. Many different types of cancer have
been reported in children admitted to MAHAK’S
Pediatric Cancer Treatment and Research Center
(MPCTRC) including acute lymphocytic
leukemia (ALL), acute myelocytic leukemia
(AML) [25], central nervous system tumors such
as primitive neuroectodermal tumor (PNET) [26],
and soft and hard tissue tumors [27].
MPCTRC is equipped with a wide range of
facilities including an operating room,
ultrasound, and laser and ozone therapy units.
Acute and chronic pain control has become
achievable with the help of transcutaneous
electrical nerve stimulation (TENS), peripheral
and central neural blockade, or epiduroscopy
(diagnosis and treatment of epidural space
adhesions resulting from spine surgery or tumor
invasion). Other interventional painmanagement
techniques accessible at this center include the use
of radiofrequency andmicrowave formodulation,
ablation, and coagulation of pain pathways,
implantable analgesic pumps in the epidural or
intrathecal space, along with botulinum toxin
Fig. 2 Progression of pain and cancer pain-related knowledge annually. About one-third of pain knowledge was developed
since 2010
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injection therapy (for headaches, muscle pains,
and spasms), photodynamic therapy,
aromatherapy, and music therapy [28]. There are
many disease-based projects undertaken at this
center [25–28]. There are also a number of
ongoing projects investigating the follow-up of
cancer patients since 2014, which are due to be
completed by 2020. The number of cancer
patients referred to MAHAK since 2008 is shown
in Table 1.
Overall, the establishment of MPCTRC has
been successful in improving the quality of life
in children affected by cancer [28]. As stated by
recent studies, each cancer center should be
supplied with a specific pain department in
order to reduce cancer patients’ distress. This is
of significant importance among physicians
[28]. MAHAK supports the treatment of
cancer-stricken children by providing them
with specialized services that still allow them
to enjoy their childhood whilst undergoing
treatment. This allow the patients to have the
highest possible quality of life in accordance
with international standards [23, 28].
CONCLUSION
There is a need to be more inventive with the
management of cancer-related issues in
developing countries to maximize the use of
available tools. With regard to the paucity of
knowledge and limited resources in this area,
the critical role of the non-governmental
organizations, such as MAHAK, should not be
overlooked.
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